Innovalve 3TB ( $300M ) Listed by handala Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

On July 26, 2024, the ransomware group handala publicly listed Innovalve, an Israeli medical-device startup recently valued in a $300 million acquisition, as a victim of a data breach involving the claimed exfiltration of 3TB of internal files. Public reporting so far rests on the group's own leak-site announcement; independent confirmation of the intrusion method, exact timeline of compromise, or full scope of material remains limited.

The listing matters because Innovalve operates in a high-stakes medical-technology sector where internal research, clinical data, and corporate records can affect patients, employees, and partner organisations. What is known is drawn solely from the group's claims and the reported acquisition details; no verified count of affected individuals has been released.

Breaking down the breach

According to the available record, handala listed Innovalve under the headline “Innovalve 3TB ($300M)” and asserted that it had exfiltrated internal files in a ransomware attack. The group’s own statement, dated around mid-July 2024, claimed it was publishing “all data about this startup for free” after monitoring the company’s acquisition. The announcement referenced the July 17 purchase of Innovalve by Edwards Lifesciences from Sheba Medical Center for 300 million dollars and framed the release as a “gift” of equivalent value. No technical details of the intrusion vector, encryption status, or ransom demand have been disclosed in the public summary. The number of people affected is listed as unknown, and no independent forensic confirmation of the 3TB figure or the precise contents has been provided in the facts available.

Inside handala

Handala is a ransomware and data-leak group that has operated publicly since at least 2023, typically combining file encryption with the threat of publishing stolen data on a dedicated leak site. The group frequently targets organisations with geopolitical or commercial significance, often releasing large archives accompanied by political messaging. Its established pattern includes monitoring high-value corporate transactions and timing leak announcements to maximise attention. In this instance the group claims it had been watching the Innovalve deal for a long time before publishing the material. Beyond that claim, no additional statements specific to Innovalve’s systems or response have been verified. Handala’s prior activity has involved both private-sector and institutional victims, with data dumps ranging from internal documents to employee records; the group’s reliability as a sole source remains subject to independent scrutiny.

Who is Innovalve 3TB ( $300M )?

Innovalve is an Israeli medical-technology startup focused on innovative heart-valve solutions, originally developed in association with Sheba Medical Center. In July 2024 the company was acquired by the U.S. firm Edwards Lifesciences for approximately 300 million dollars, a transaction that elevated its commercial profile. Organisations of this type routinely hold proprietary research data, clinical-trial documentation, employee records, supplier contracts, and intellectual-property files. A breach involving such an entity is consequential because medical-device firms sit at the intersection of patient safety, regulatory compliance, and competitive intellectual property; any exposure can affect ongoing product development, partner relationships, and the privacy of individuals connected to the company.

The information in question

The facts state only that “internal files” were exfiltrated in a ransomware attack and that the group claimed a 3TB volume. Exact data types beyond that description are not disclosed. Organisations in the medical-device sector typically maintain research and development files, clinical and regulatory documentation, employee and contractor personal information, financial records related to funding and acquisition, and correspondence with hospitals or partners. Because the precise contents remain unconfirmed, it is not possible to state which of these categories, if any, appear in the claimed archive. The group’s announcement refers to “all data about this startup,” but that assertion has not been independently verified.

The real-world impact

For individuals whose information may be present, the primary risks include identity misuse, targeted phishing, or unwanted contact if personal or professional details surface. Employees, researchers, and clinical collaborators could face secondary effects such as credential compromise or reputational exposure. For the organisation itself, the release of internal files can disrupt ongoing research programmes, complicate regulatory filings, and strain relationships with the new parent company and medical partners. Because the number of people affected is unknown and the exact data types unconfirmed, the full scale of harm cannot yet be quantified; the impact remains potential rather than fully measured.

What to do if you're exposed

If you believe you may have been connected to Innovalve as an employee, contractor, patient, or partner, take the following practical steps:

• Monitor financial and email accounts for unusual activity and enable multi-factor authentication where available.
• Change passwords on any accounts that may have reused credentials linked to work or clinical systems.
• Watch for phishing messages that reference the company, the acquisition, or medical research.
• Request credit or identity monitoring services if personal identifiers are later confirmed to have been involved.
• Run a free exposure scan of your email address against known breach data sets to check whether your information has already appeared in public leak collections.

Public detail remains limited; continue to follow official statements from the company or relevant authorities for verified updates rather than relying solely on the threat actor’s claims.

AICompiled with AI assistance from public sources and published under our editorial standards.